Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

M&S resumes online orders after cyber attack

(Sharecast News) - Marks & Spencer is to start taking some online orders again, the retailer confirmed on Tuesday, six weeks after it was rocked by a major cyber attack. The high street chain said a selection of fashion ranges were now available to buy online for home delivery in England, Wales and Scotland.

More items, including beauty and homeware products, will also be made available "in the coming weeks", it confirmed.

The high street giant was forced to halt all online orders after hackers attacked over the Easter weekend in late April.

Click and collect and contactless payments were affected, shelves were left empty and some customer details were stolen, including addresses and dates of birth. Online orders were suspended a few days following the attack.

M&S has already warned that the attack will likely hit profits by around £300m in the current year.

In a brief statement, John Lyttle, managing director of fashion, home and beauty, said: "More of our fashion, home and beautify products will be added every day, and we will resume deliveries to Northern Ireland and click and collect in the coming weeks."

Russ Mould, investment director at AJ Bell, said M&S was taking a "step-by-step approach".

He continued: "The retailer will want to make sure everything is functioning smoothly before turning all the lights back on, as it cannot risk any further disruption to customers. It's already having to work hard to regain their trust."

As at 1100 BST, shares in M&S were up 3% at 372p.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.